Literature DB >> 16094220

Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya.

Kiprotich Chelimo1, Ayub V Ofulla, David L Narum, James W Kazura, David E Lanar, Chandy C John.   

Abstract

BACKGROUND: Antibodies are important in protection against infection and disease caused by Plasmodium falciparum, but the frequencies of antibodies to multiple P. falciparum antigens in children are not well-characterized.
METHODS: IgG and IgM antibodies to the vaccine candidate antigens circumsporozoite protein, thrombospondin-related adhesive protein, liver stage antigen-1, apical membrane antigen-1, erythrocyte-binding antigen-175 and merozoite surface protein-1 were measured by enzyme-linked immunosorbent assay in 110 children 0-50 months of age in a malaria holoendemic area of Kenya.
RESULTS: A similar pattern was seen for IgG antibodies to circumsporozoite protein, thrombospondin-related adhesive protein, apical membrane antigen-1 and erythrocyte-binding antigen-175: high frequencies (70-90%) in children 0-4 months of age; a decrease in children 5-20 months of age (35-71%); and progressive increases in children 21-36 and 37-50 months of age (53-80% and 60-100%, respectively). In contrast, IgG antibodies to liver stage antigen-1 were infrequent in children 0-4 months of age (5%) and increased with age to 64%, and IgG antibody frequencies to merozoite surface protein-1 were similar across age groups (26-52%). IgG antibodies to all antigens were predominantly of the IgG1 and IgG3 subclasses. Frequencies of IgM antibodies to all antigens were low in children 0-4 months of age (0-15%) and increased with age (24-56% in the oldest children).
CONCLUSION: In children in a malaria-holoendemic area, IgM antibody to all P. falciparum antigens is infrequent in the first 4 months of life but increases with age and increased exposure. The pattern of age-related IgG response frequencies to P. falciparum antigens varies significantly by antigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094220     DOI: 10.1097/01.inf.0000172151.28851.fd

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Humoral immune responses to Plasmodium falciparum among HIV-1-infected Kenyan adults.

Authors:  Obinna N Nnedu; Michael P O'Leary; Daniel Mutua; Beth Mutai; Mina Kalantari-Dehaghi; Al Jasinskas; Rie Nakajima-Sasaki; Grace John-Stewart; Phelgona Otieno; Xiaowu Liang; John Waitumbi; Francis Kimani; David Camerini; Philip L Felgner; Judd L Walson; Adam Vigil
Journal:  Proteomics Clin Appl       Date:  2011-12       Impact factor: 3.494

2.  Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.

Authors:  Gregory S Noland; Brett Hendel-Paterson; Xinan M Min; Ann M Moormann; John M Vulule; David L Narum; David E Lanar; James W Kazura; Chandy C John
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

3.  IgG antibody response against Plasmodium falciparum aminopeptidase 1 antigen in Gabonese children living in Makokou and Franceville.

Authors:  S L Oyegue-Liabagui; R-K Imboumy-Limoukou; C L Kouna; F Bangueboussa; M Schmitt; I Florent; J B Lekana-Douki
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

4.  Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.

Authors:  Gregory S Noland; Paul Jansen; John M Vulule; Gregory S Park; Bartholomew N Ondigo; James W Kazura; Ann M Moormann; Chandy C John
Journal:  Acta Trop       Date:  2014-10-24       Impact factor: 3.112

5.  Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.

Authors:  David L Narum; Solabomi A Ogun; Adrian H Batchelor; Anthony A Holder
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.

Authors:  Sumi Biswas; Matthew D J Dicks; Carole A Long; Edmond J Remarque; Loredana Siani; Stefano Colloca; Matthew G Cottingham; Anthony A Holder; Sarah C Gilbert; Adrian V S Hill; Simon J Draper
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

7.  The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission.

Authors:  Sarah I Nogaro; Julius C Hafalla; Brigitte Walther; Edmond J Remarque; Kevin K A Tetteh; David J Conway; Eleanor M Riley; Michael Walther
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

8.  Suppression of circulating IgD+CD27+ memory B cells in infants living in a malaria-endemic region of Kenya.

Authors:  Amolo S Asito; Erwan Piriou; Walter G Z O Jura; Collins Ouma; Peter S Odada; Sidney Ogola; Nancy Fiore; Rosemary Rochford
Journal:  Malar J       Date:  2011-12-13       Impact factor: 2.979

9.  Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.

Authors:  Arlene E Dent; Kiprotich Chelimo; Peter O Sumba; Michele D Spring; Brendan S Crabb; Ann M Moormann; Daniel J Tisch; James W Kazura
Journal:  Malar J       Date:  2009-07-16       Impact factor: 2.979

10.  Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.

Authors:  Cleopatra K Mugyenyi; Salenna R Elliott; Fiona J McCallum; Robin F Anders; Kevin Marsh; James G Beeson
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.